Year |
Citation |
Score |
2016 |
Chattopadhyay AK, Menz H, Ly VL, Dorich S, Hanessian S. Synthesis of a Model Tetracyclic Core Structure of Calyciphylline B-Type Alkaloids. The Journal of Organic Chemistry. PMID 26878089 DOI: 10.1021/Acs.Joc.5B02875 |
0.639 |
|
2016 |
Büschleb M, Dorich S, Hanessian S, Tao D, Schenthal KB, Overman LE. Synthetic Strategies toward Natural Products Containing Contiguous Stereogenic Quaternary Carbon Atoms. Angewandte Chemie (International Ed. in English). PMID 26836448 DOI: 10.1002/Anie.201507549 |
0.564 |
|
2016 |
Büschleb M, Dorich S, Hanessian S, Tao D, Schenthal KB, Overman LE. Strategien für die Synthese von Naturstoffen mit benachbarten stereogenen quartären Kohlenstoffatomen Angewandte Chemie. 128: 4226-4258. DOI: 10.1002/Ange.201507549 |
0.541 |
|
2014 |
Dorich S, Del Valle JR, Hanessian S. Synthesis of functionalized octahydroindoles related to daphnyphyllum alkaloids Synlett. 25: 799-804. DOI: 10.1055/S-0033-1340794 |
0.679 |
|
2014 |
Hanessian S, Dorich S, Kassem S, Menz H, Chattopadhyay AK. Stereocontrolled synthesis of all-syn 3,4-disubstituted l-prolines: Studies of the reductive rearrangement of unactivated tertiary allylic alcohols Tetrahedron. 70: 439-449. DOI: 10.1016/J.Tet.2013.11.040 |
0.674 |
|
2013 |
Hanessian S, Dorich S, Chattopadhyay AK, Büschleb M. Studies toward the generation of functionalized quaternary carbon centers relying on Wittig and Wittig-Still allylic ether anionic transpositions. The Journal of Organic Chemistry. 78: 8915-21. PMID 23915281 DOI: 10.1021/Jo401488Y |
0.573 |
|
2013 |
Hanessian S, Dorich S, Menz H. Concise and stereocontrolled synthesis of the tetracyclic core of daphniglaucin C. Organic Letters. 15: 4134-7. PMID 23889206 DOI: 10.1021/Ol4018112 |
0.609 |
|
2013 |
Tourigny DS, Fernández IS, Kelley AC, Vakiti RR, Chattopadhyay AK, Dorich S, Hanessian S, Ramakrishnan V. Crystal structure of a bioactive pactamycin analog bound to the 30S ribosomal subunit. Journal of Molecular Biology. 425: 3907-10. PMID 23702293 DOI: 10.1016/J.Jmb.2013.05.004 |
0.521 |
|
2013 |
Hanessian S, Vakiti RR, Chattopadhyay AK, Dorich S, Lavallée C. Probing functional diversity in pactamycin toward antibiotic, antitumor, and antiprotozoal activity. Bioorganic & Medicinal Chemistry. 21: 1775-86. PMID 23434136 DOI: 10.1016/J.Bmc.2013.01.037 |
0.535 |
|
2012 |
Hanessian S, Vakiti RR, Dorich S, Banerjee S, Deschênes-Simard B. Total synthesis of pactamycin and pactamycate: a detailed account. The Journal of Organic Chemistry. 77: 9458-72. PMID 23083207 DOI: 10.1021/Jo301638Z |
0.663 |
|
2011 |
Hanessian S, Vakiti RR, Dorich S, Banerjee S, Lecomte F, DelValle JR, Zhang J, Deschênes-Simard B. Total synthesis of pactamycin. Angewandte Chemie (International Ed. in English). 50: 3497-500. PMID 21370372 DOI: 10.1002/Anie.201008079 |
0.658 |
|
2011 |
Hanessian S, Soma U, Dorich S, Deschênes-Simard B. Total synthesis of (+)-ent-cyclizidine: absolute configurational confirmation of antibiotic M146791. Organic Letters. 13: 1048-51. PMID 21271743 DOI: 10.1021/Ol103094J |
0.64 |
|
2011 |
Hanessian S, Vakiti RR, Dorich S, Banerjee S, Lecomte F, DelValle JR, Zhang J, Deschênes-Simard B. Cover Picture: Total Synthesis of Pactamycin (Angew. Chem. Int. Ed. 15/2011) Angewandte Chemie International Edition. 50: 3325-3325. DOI: 10.1002/Anie.201101592 |
0.627 |
|
2011 |
Hanessian S, Vakiti RR, Dorich S, Banerjee S, Lecomte F, DelValle JR, Zhang J, Deschênes-Simard B. Titelbild: Total Synthesis of Pactamycin (Angew. Chem. 15/2011) Angewandte Chemie. 123: 3383-3383. DOI: 10.1002/Ange.201101592 |
0.659 |
|
Low-probability matches (unlikely to be authored by this person) |
2016 |
Bueschleb M, Dorich S, Hanessian S, Tao D, Schenthal KB, Overman LE. ChemInform Abstract: Synthetic Strategies Toward Natural Products Containing Contiguous Stereogenic Quaternary Carbon Atoms Cheminform. 47. DOI: 10.1002/chin.201619225 |
0.164 |
|
2020 |
Dorich S, Cox JH, Burch JD, Chagnon F, Chen B, Léger S, St-Onge M, Fader LD. Novel pyridone EP agonists featuring allylic alcohol ω-chains. Bioorganic & Medicinal Chemistry Letters. 127104. PMID 32201020 DOI: 10.1016/J.Bmcl.2020.127104 |
0.157 |
|
2022 |
Bubenik M, Mader P, Mochirian P, Vallée F, Clark J, Truchon JF, Perryman AL, Pau V, Kurinov I, Zahn KE, Leclaire ME, Papp R, Mathieu MC, Hamel M, Duffy NM, ... ... Dorich S, et al. Identification of , an Orally Bioavailable Compound that Inhibits the DNA Polymerase Activity of Polθ. Journal of Medicinal Chemistry. PMID 36126059 DOI: 10.1021/acs.jmedchem.2c00998 |
0.107 |
|
2024 |
Black WC, Abdoli A, An X, Auger A, Beaulieu P, Bernatchez M, Caron C, Chefson A, Crane S, Diallo M, Dorich S, Fader LD, Ferraro GB, Fournier S, Gao Q, et al. Discovery of the Potent and Selective ATR Inhibitor Camonsertib (RP-3500). Journal of Medicinal Chemistry. PMID 38299539 DOI: 10.1021/acs.jmedchem.3c01917 |
0.094 |
|
2021 |
Roulston A, Zimmermann M, Papp R, Skeldon A, Pellerin C, Dumas-Bérube É, Dumais V, Dorich S, Fader LD, Fournier S, Li L, Leclaire ME, Yin SY, Chefson A, Alam H, et al. RP-3500: A Novel, Potent and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors. Molecular Cancer Therapeutics. PMID 34911817 DOI: 10.1158/1535-7163.MCT-21-0615 |
0.071 |
|
2023 |
St-Onge M, Chefson A, Wu J, Caron-Duval É, Dumais V, Dorich S, Cox J, Caron A, Burch J, Percival MD, Therien AG, Fader LD. Discovery of NXT-10796, an orally active, intestinally restricted EP4 agonist prodrug for the treatment of inflammatory bowel disease. Bioorganic & Medicinal Chemistry Letters. 91: 129351. PMID 37270073 DOI: 10.1016/j.bmcl.2023.129351 |
0.044 |
|
Hide low-probability matches. |